MedTrace Logo

Virtual Reality for Pain and Anxiety in Pediatric Dental Treatment

NCT07636330 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-07-02

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether immersive virtual reality (VR) reduces pain and anxiety in children aged 6-12 years during routine dental procedures. The main questions it aims to answer are:

* Does VR distraction reduce self-reported pain and anxiety during dental treatment compared to standard behaviour guidance?
* Does VR distraction improve children's post-procedural experience and willingness to return for future dental visits?

Researchers will compare children using a VR headset during dental treatment to children receiving standard behaviour guidance techniques.

Participants will:

* Attend one routine dental appointment
* Be randomly assigned to wear a VR headset or receive standard care during their procedure
* Complete brief questionnaires about pain and anxiety before and after treatment
* Receive a follow-up phone call 24-72 hours after the appointment

Conditions

  • Dental Anxiety in Children
  • Pain

Interventions

DEVICE

Immersive Virtual Reality Headset

A commercially available immersive VR headset used as a non-pharmacological distraction tool during routine pediatric dental procedures. Children wear the headset throughout their treatment to engage with an interactive virtual environment designed to reduce pain and anxiety.

BEHAVIORAL

Standard Behaviour Guidance

Standard behaviour guidance techniques routinely used in pediatric dentistry, including tell-show-do, positive reinforcement, and distraction through verbal communication and a TV screen. No virtual reality headset is used.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-02
Primary Completion
2027-06-18
Completion
2027-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07636330 on ClinicalTrials.gov